Meeting
2016 ASCO Annual Meeting
Salvage surgery with abdominoperineal excision of the rectum (APER) following loco-regional failure after chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance 5FU/CisP chemotherapy (CT) in squamous cell carcinoma of the anus (SCCA) and the impact on long-term outcomes: Results of ACT II.
Authors
Robert Glynne-Jones
Mount Vernon Cancer Centre, Middlesex, United Kingdom
Robert Glynne-Jones , Helen Margaret Meadows , Andre Lopes , Richard A. Adams , Leslie M. Samuel , James Hill , Andrew Renehan , Maria A Hawkins , David Sebag-Montefiore
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Anal Cancer
Clinical Trial Registration Number
26715889
Citation
J Clin Oncol 34, 2016 (suppl; abstr 3523)
DOI
10.1200/JCO.2016.34.15_suppl.3523
Abstract #
3523
Poster Bd #
220
Abstract Disclosures
Similar Posters
First Author: Robert Glynne-Jones
Poster
2013 ASCO Annual Meeting
Tumor-related and treatment-related colostomy-free survival (CFS) following chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance 5FU/CisP chemotherapy (CT) in squamous cell carcinoma of the anus (SCCA): Results of ACT II.
First Author: Robert Glynne-Jones
Poster
2011 Gastrointestinal Cancers Symposium
Cisplatin (C) based chemoradiation (CXRT) for locally advanced squamous cell carcinoma (SCCA) of the anal canal (AC): A 20-year perspective.
First Author: Cathy Eng
Poster
2021 Genitourinary Cancers Symposium
Pembrolizumab (pembro) plus chemoradiotherapy (CRT) versus placebo plus CRT for patients (pts) with muscle-invasive bladder cancer (MIBC): The phase III KEYNOTE-992 study.
First Author: Andrew James Weickhardt